The Sunovion Long-Term Care Team are proud sponsors of #DDNA 31st Educational Conference in New Orleans from April 14-17, 2023. Please stop by the Sunovion Booth to say hello. We are looking forward to engaging with nurses that serve the special needs of patients with developmental disabilities.

Connect with us anytime at: https://lnkd.in/eHJCQRiZ

Did you know that Bipolar Disorder affects nearly 3% of adults in the US? (1)

Bipolar Disorder is a chronic mood disorder characterized by mood swings from extreme highs (mania) to extreme lows (depression). Bipolar Depression is an important contributor to long-term dysfunction for patients due to psychosocial impairment and impaired quality of life. (2)

As a patient-focused leader in the CNS space, the Medical and Scientific Affairs Team at Sunovion Pharmaceuticals is proud to contribute to relevant and important literature for people living with bipolar depression. #bipolardepression #BPD

To learn more about this publication, connect with your Field Medical Representative: https://bit.ly/3sHZR8J

The #Sunovion Neurology team had an exciting week at the 4th Pan American Parkinson’s Disease and Movement Disorders Congress (MDS-PAS) in Miami, Florida! The team supported multiple poster presentations, including one highlighting guidance from a Delphi consensus panel on the use of on-demand therapies for OFF episodes in Parkinson’s Disease. #pascongress #neurology

Connect with our Field Medical team to find out what you missed:
https://bit.ly/3sHZR8J

#Sunovion360 supports your efforts to integrate behavioral and physical health for better population health management.

Access the Behavioral Health Screening Toolkit for materials that can be customized for your health plan, system or facility https://bit.ly/3lLbqYG

The #SunovionLTC Team is looking forward to #DDNA in San Antonio! We proudly support your mission to educate, empower, and advocate for nurses practicing in the specialty of developmental disability nursing.

Hope to see you at DDNA in San Antonio!